Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Revenio Group Oyj
  6. Summary
    REG1V   FI0009010912

REVENIO GROUP OYJ

(REG1V)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Helsinki
11/22/2021 11/23/2021 11/24/2021 11/25/2021 11/26/2021 Date
56.2(c) 55.75(c) 54.95(c) 55.85(c) 54.95(c) Last
16 981 20 347 48 771 10 485 27 596 Volume
-3.19% -0.80% -1.43% +1.64% -1.61% Change
More quotes
Estimated financial data (e)
Sales 2021 77,2 M 87,4 M 87,4 M
Net income 2021 17,0 M 19,2 M 19,2 M
Net Debt 2021 2,61 M 2,95 M 2,95 M
P/E ratio 2021 86,0x
Yield 2021 0,63%
Sales 2022 92,0 M 104 M 104 M
Net income 2022 21,3 M 24,1 M 24,1 M
Net cash position 2022 8,31 M 9,41 M 9,41 M
P/E ratio 2022 68,5x
Yield 2022 0,71%
Capitalization 1 460 M 1 652 M 1 652 M
EV / Sales 2021 18,9x
EV / Sales 2022 15,8x
Nbr of Employees 158
Free-Float 84,3%
More Financials
Company
Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material... 
More about the company
Ratings of Revenio Group Oyj
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about REVENIO GROUP OYJ
11/26REVENIO GROUP CORPORATION : Revenio Group's financial reporting and Annual General Meeting..
AQ
11/16REVENIO GROUP CORPORATION : The Chairman of the Board of Revenio will resign at the spring..
AQ
10/21REVENIO GROUP CORPORATION : Interim report January 1 - September 30, 2021
AQ
10/19REVENIO GROUP CORPORATION : Invitation to Revenio Group Corporation's audiocast and teleco..
AQ
09/20REVENIO OYJ : Group Corporation - Managers' Transactions
AQ
08/05REVENIO GROUP CORPORATION : Half-year financial report 1 January-30 June 2021
AQ
08/05Revenio Group Oyj Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
08/04REVENIO GROUP CORPORATION : Revenio updates its financial guidance for 2021
AQ
08/04Revenio Group Corporation Reaffirms Earnings Guidance for the Full Year 2021
CI
07/27REVENIO GROUP CORPORATION : Invitation to Revenio's audiocast and teleconference in relati..
AQ
06/18REVENIO GROUP CORPORATION : Hanna Vuornos appointed Director, People&Culture and as a memb..
AQ
06/18Revenio Group Corporation Appoints Hanna Vuornos as Director, People&Culture and as a M..
CI
06/15REVENIO GROUP CORPORATION : Increased number of shares entered into trade register
AQ
05/28REVENIO GROUP CORPORATION : Transfer of the Company's own shares
AQ
05/28REVENIO GROUP CORPORATION : Appointment to Revenio's Leadership Team
AQ
More news
News in other languages on REVENIO GROUP OYJ
09/13Small caps – les derniers choix des stars de la gestion
2020REVENIO GROUP OYJ : une autorisation de mise sur le marché fait bondir le titre
More news
Chart REVENIO GROUP OYJ
Duration : Period :
Revenio Group Oyj Technical Analysis Chart | REG1V | FI0009010912 | MarketScreener
Technical analysis trends REVENIO GROUP OYJ
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Last Close Price 54,95 €
Average target price 59,87 €
Spread / Average Target 8,95%
EPS Revisions
Managers and Directors
Jouni Erik Toijala President & Chief Executive Officer
Robin Allan Pulkkinen Chief Financial Officer
Pekka Veikko Juhani Rönkä Chairman
Mika Salkola Director-Research & Development
Ari Isomäki Operations Director
Sector and Competitors
1st jan.Capi. (M$)
REVENIO GROUP OYJ9.24%1 652
SARTORIUS AG49.28%42 386
BIOTAGE AB (PUBL)89.21%1 906
VAREX IMAGING CORPORATION76.68%1 162
CELLAVISION AB (PUBL)15.90%932
908 DEVICES INC.-59.00%651